humour412
humour412
About

Main focus on small-mid cap commercial biotech with solid pipeline/platform. ๐Ÿ‘€ for substantial growth with best risk-adj returns. Long AXGN, NBIX, SUPN, CORT, NVCR, LGIH, AKAO, OMER. Oh and don't be a ๐Ÿ‘ ๐Ÿ˜. Vast majority cannot even beat the S&P 500.

  • Member since October 26th 2017
  • Equities, Growth
Post